SENS News
Donations being triple matched for SENS end-of-year fundraiser
SENS Research Foundation - 01-Dec-2020
I've just donated to help #UnlockLongevity - these are the experts and they need funding!
Read more...Forever Healthy Fellowship Program awarded to Dr. Tesfahun Admasu
Forever Healthy Foundation - 23-Jun-2020
His project researches on secondary senescent cells and SASP
Read more...SENS OncoSENS project suspended due to lack of funds and progress
Lifespan.io (LEAF) - 14-Jun-2020
It's important to keep funding basic research as no one knows where the answers will lie
Read more...Is senescent cell clearance a zero sum game?
SENS Research Foundation - 06-Oct-2019
Research suggests senolytic treatments will be beneficial for at least a few decades
Read more...Interview with Aubrey de Grey - Longevity.Technology Exclusive
Longevity Technology - 12-Sep-2019
Great intro to life extension's leading advocate - Aubrey predicts radical change within 5 years
Read more...Aubrey de Grey shortens timeframe for human rejuvenation
Next Big Future - 28-Feb-2019
Once proven in mice, demand and funding will surge
Read more...Aubrey de Grey predicts age reversal trials in 5 years
Lifespan.io (LEAF) - 13-Dec-2018
Not yet predicting the end of aging, but first generation damage repair therapies.
Read more...2019 SRF Summer Scholars Program - applications open now
SENS Research Foundation - 01-Dec-2018
Great opportunity to work with some of the best minds in aging research
Read more...Josh Mitteldorf thinks his and Aubrey de Grey's views are converging
Aging Matters - 08-Oct-2018
Even if signaling is fix, I suspect that there will be some damage already done that needs repairing
Read more...SRF has made progress in the fight against ageing
Lifespan.io (LEAF) - 05-Dec-2017
R&D phase in SENS repair approach has shown promising results
Read more...SRF to develop glucosepane-cleaving antibodies with Spiegel Lab
Lifespan.io (LEAF) - 17-Sep-2017
Anti-glucosepane antibodies may offer new therapies for age-related diseases
Read more...
